Headline
The latest stories from AHA Today.
The White House Supply Chain Task Force projects the nation will have enough N95 masks to meet pandemic demand for July through October, according to a report released to the Senate Homeland Security and Governmental Affairs Committee for a hearing on federal efforts to procure and distribute…
AHA submitted comment to the Centers for Medicare & Medicaid Services on the agency’s proposed skilled nursing facility prospective payment system for fiscal year 2021, urging CMS to support additional funds to offset the cost of critically important COVID-19 testing.
Each June “What Matters to You?” Day aims to encourage meaningful conversations between people who provide and receive health and social care.
The Internal Revenue Service released proposed regulations addressing the treatment of direct primary care arrangements, health care sharing ministry memberships and certain government-sponsored health care programs under section 213 of the Internal Revenue Code.
The Food and Drug Administration does not intend to object to a manufacturer or authorized distributor delivering prescription drug samples directly to licensed practitioners or their patients at their homes during the COVID-19 emergency when requested by the practitioner in accordance with…
The Centers for Medicare & Medicaid Services released a guide for patients considering in-person, non-emergency treatment as the country continues to reopen and COVID-19 cases decline.
The Department of Health and Human Services announced in an email that it is planning an additional distribution of funds to hospitals that have been particularly affected by the increased burden of caring for those with COVID-19.
The Department of Health and Human Services announced that it will distribute $10 billion from the Public Health and Social Services Emergency Fund to hospitals that serve a disproportionate number of Medicaid patients or provide large amounts of uncompensated care.
The Internal Revenue Service issued a proposed rule implementing a provision of the Tax Cuts and Jobs Act of 2017 that imposed a 21% excise tax on certain executive compensation paid by tax-exempt organizations.
FDA released new guidance that expands for the duration of the COVID-19 emergency the availability and capability of non-invasive monitoring devices.